Rectify Presents Preclinical Data on RTY-694 at Liver Meeting 2024
18 Nov 2024 //
GLOBENEWSWIRE
Rectify Hosts R&D Event on RTY-694 for PSC & Liver Diseases
12 Nov 2024 //
GLOBENEWSWIRE
Rectify Pharma Names RTY-694 As Candidate For PSC
22 Oct 2024 //
GLOBENEWSWIRE
Rectify drug repairs bile composition in mice with liver disease
22 Oct 2024 //
FIERCE BIOTECH
Rectify Pharmaceuticals Presents Data At AASLD Annual Meeting
17 Oct 2024 //
GLOBENEWSWIRE
Rectify Pharmaceuticals Appoints Pol Boudes as Chief Medical Officer
03 Sep 2024 //
GLOBENEWSWIRE
Rectify Pharmaceuticals Appoints Bharat Reddy as Chief Business Officer
15 Jul 2024 //
GLOBENEWSWIRE
Rectify Expands Drug Development Expertise with Board and SAB Appointments
14 Feb 2023 //
BUSINESSWIRE
Rectify Announces Publication of Trends in Molecular Medicine Review Article
12 Dec 2022 //
BUSINESSWIRE
Rectify Pharma Appoints Robert Hughes as Executive VP & Xiaobing Li as CDO
06 Oct 2022 //
BUSINESSWIRE